Jane Lanier
Child & Adolescent Psychiatry · Atlanta, GANPI 1336435262
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.
Across 121 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$454
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$283
- Corium, LLC$198
- Otsuka America Pharmaceutical, Inc.$193
- Bausch Health US, LLC$173
- Teva Pharmaceuticals USA, Inc.$172
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,52396%
- Education$964%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 19 | $454 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $283 |
| Corium, LLC | 11 | $198 |
| Otsuka America Pharmaceutical, Inc. | 10 | $193 |
| Bausch Health US, LLC | 9 | $173 |
| Teva Pharmaceuticals USA, Inc. | 5 | $172 |
| Tris Pharma Inc | 8 | $166 |
| Noven Therapeutics, LLC | 6 | $134 |
| Ironshore Pharmaceuticals Inc. | 5 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $109 |
| Neurocrine Biosciences, Inc. | 5 | $97 |
| Collegium Pharmaceutical, Inc. | 5 | $91 |
| Lundbeck LLC | 5 | $85 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| AbbVie | 2 | $59 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Neos Therapeutics, LP | 2 | $42 |
| Johnson & Johnson | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Tempus AI, Inc | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $16 |
How this compares
$2,620 in reported general payments places this provider in the 80th percentile of 91 child & adolescent psychiatry providers in Georgia.
See all child & adolescent psychiatry providers in Georgia →
Other child & adolescent psychiatry in Atlanta
- Suneel KatragaddaAtlanta$460K
- Olujimi AdefisanAtlanta$14K
- Mhd AlkhatibAtlanta$7K
- Mary HuberAtlanta$7K
- Douglas ChanAtlanta$4K
- Satyanarayana GedelaAtlanta$3K
- Ericka GoodwinAtlanta$1K
- Kerry SheahanAtlanta$1K
- Debora JohnsonAtlanta$695
- Melanie PointerAtlanta$669
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.